摘要
目的:建立HPLC-UV法测定多西他赛注射剂中多西他赛含量。方法:采用COSMOSIL 5C18-MS-II色谱柱(5μm,250mm×4.6 mm),以0.1%磷酸水溶液(A)-乙腈(B)为流动相,等度洗脱,流速1.0 m L/min,柱温30℃,紫外检测波长230 nm。结果:在选定条件下,多西他赛峰与内标紫杉醇峰分离良好,两者峰面积之比与多西他赛浓度在0.5~32μg/m L范围内具有良好线性关系,r=0.9999;平均回收率在100.1%~103.9%,RSD<3.7%。结论:经方法学验证表明,该方法可用于多西他赛注射液中药物含量测定。
Objective: To establish an HPLC-UV method for determining docetaxel in docetaxel injection. Methods: The separation was performed on the COSMOSIL 5C18-MS-II( 4. 6mm × 250 mm,5μm). The mobile phase consisted of 0. 1% mol / L phosphoric acid( A) and acetonitrile( B) with an isocratic elution at a flow rate of 1. 0m L/min. The column temperature was 30℃,and the detection wavelength was at 230 nm. Results: Under the described condition,docetaxe was completely separated from paclitaxel. Good linear relationship was observed between the peak area ratio of docetaxel and paclitaxel and concentration in the range of 0. 5 ~ 32μg / m L,r =0. 9999. The average recovery of docetaxel ranged from 100. 1% to 103. 9%. The relative standard deviations were less than 3. 7%.Conclusion: It is confirmed by the methodology validation that the quantification method is applicable to the quality control of docetaxel of docetaxel for injection.
出处
《淮海医药》
CAS
2017年第2期142-144,共3页
Journal of Huaihai Medicine